Physician profile
Chase Thomas
NPI 1255859930
$747.06
in general payments reported to CMS, 2019-2025
6 companies · $254 in 2025
The $254 reported for 2025 was more than what 80% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.58 · 2020: $127 · 2022: $85.22 · 2023: $28.95 · 2024: $240 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.28 |
| Education | $234.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Colgate Oral Pharmaceuticals, INC. | $321.20 | 2020-2024 | |
| Zimvie INC. | $235.65 | 2024-2025 | |
| Ivoclar Vivadent, INC. | $98.50 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $48.87 | 2019-2025 | Arestin |
| Align Technology, INC. | $28.95 | 2023 | Itero Element 5d Plus Lite, Itero Element 5d Plus, Itero Element 2 |
| Envista Holdings Corporation | $13.89 | 2024 | Nexus Rmgi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.